Cabozantinib + NIVOLUMAB + IPILIMUMAB

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Cabozantinib + NIVOLUMAB + IPILIMUMAB
Treatment and conditionWhere it standsTrials
Cabozantinib + NIVOLUMAB + IPILIMUMAB for neoplasmsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1